BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 19 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $17,825,000 | +16.0% | 5,000,000 | 0.0% | 0.01% | +10.0% |
| Q2 2014 | $15,365,000 | -8.7% | 5,000,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $16,830,000 | -3.2% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $17,385,000 | -3.2% | 5,000,000 | 0.0% | 0.01% | -7.7% |
| Q3 2013 | $17,960,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Amici Capital, LLC | 8,000,000 | $35,720,000 | 1.61% |
| Baker Brothers Advisors | 22,898,000 | $102,104,000 | 1.04% |
| CITIGROUP INC | 6,176,000 | $27,560,000 | 0.02% |
| SG Americas Securities, LLC | 10,000 | $4,465,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 37,000 | $165,000 | 0.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,462,000 | 0.00% |
| Allianz Asset Management GmbH | 300,000 | $1,340,000 | 0.00% |
| UBS Group AG | 22,000 | $98,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,000 | $8,000 | 0.00% |
| MORGAN STANLEY | 11,000 | $49,000 | 0.00% |